Research and Markets: Assessment of the 530 Deals and Alliances That Took Place Between 2000 and 2005 for Respiratory Diseases
Posted on: Friday, 1 July 2005, 12:01 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c20168) has announced the addition of Deals and Alliances Therapy Report - Respiratory Diseases to their offering.
Deals and Alliances Therapy Report - Respiratory Diseases provides an in-depth view of over 530 deals and alliances announced in respiratory diseases between 2000 and 2005, in a clear and accessible PDF format.
The report contains:
-- fully categorized deal overviews
-- financial information where disclosed
-- company profiles of the top 25 dealmakers in the report
-- specialized indexes including deal type, therapy area, industry sector and stage of development
-- an alphabetical index of company activity.
The report helps in:
-- identifying active partners
-- tracking competitor activity
-- benchmarking deals
-- comparing the finances of different deal types.
Deals and Alliances Therapy Report - Respiratory Diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in respiratory diseases.
This report is essential reading for board and executive management, and individuals in:
-- business development
-- licensing/partnering
-- deal making
-- business strategy
-- marketing and promotion
-- distribution and manufacturing (including contract services).
Introduction
A summary of the deals and dealmakers over a five-year period. Includes charts and tables summarizing activity in the therapy area.
Deals by company
A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.
Deals by development stage
A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.
Summary profiles for the most active companies
Summary profiles for the most active companies in the therapy area over the past five years, including history, business strategy, partnering strategy, and deals listing.
List of deals
A full index of all the deals announced between May 2000 and April 2005. Entries contain financial information such as headline value, upfront and royalty rates, where available.
Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed, and links to the full deal in the deal listing at the rear of each report
List of Charts:
-- Deal activity 2000-2005
-- Deal activity last 12 months
-- Deal activity in respiratory diseases by year
-- Deal activity in respiratory diseases by type
-- Deal activity in respiratory diseases by development stage
For more information visit http://www.researchandmarkets.com/reports/c20168.
Source: Business Wire
Related Articles
- Argenta and Dr Reddy's Reach Milestone in Respiratory Disease
- Argenta Discovery and Dr. Reddy's Progress Pre-Clinical Anti-Inflammatory Candidate to Treat Chronic Respiratory Disease
- Disease and Therapy Review: End Stage Renal Disease
- Disease and Therapy Review: Obesity Was Developed to Provide a Basic Understanding of the Key Facts About Obesity and Market in a Quick Easy to Read Format
- MedImmune Broadens Efforts to Develop Vaccines to Help Prevent RSV and Other Important Pediatric Respiratory Diseases
- Launch of Global Alliance Against Chronic Respiratory Diseases (GARD)
- ImQuest Pharmaceuticals and Samjin Pharmaceutical Co. Form Strategic Drug Development Alliance
- Illinois Technology Development Alliance Announces Two New Board Members
- The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial
User Comments (0)

RSS Feeds